Biologics versus functional endoscopic sinus surgery for the treatment of chronic rhinosinusitis with nasal polyps: a literature review
- PMID: 37993118
- DOI: 10.1017/S0022215123002177
Biologics versus functional endoscopic sinus surgery for the treatment of chronic rhinosinusitis with nasal polyps: a literature review
Abstract
Objective: To review the literature comparing functional endoscopic sinus surgery to dupilumab for the treatment of chronic rhinosinusitis with nasal polyps, in terms of symptom control, cost-effectiveness and complications.
Method: A literature review was conducted using PubMed, ScienceDirect and Cochrane databases. Data were extracted manually.
Results: A total of six papers relevant to the main objective were found.
Conclusion: Chronic rhinosinusitis with nasal polyps has a significant impact on patients' quality of life. Both functional endoscopic sinus surgery and dupilumab achieve comparable disease control and result in good symptom relief. Dupilumab is far more expensive than functional endoscopic sinus surgery and is not considered cost-effective for the time being. This is expected to change after 10 years when the drug patent expires. More research is needed to compare the complications of both treatment modalities.
Keywords: Nasal polyps; endoscopic surgical procedure; immunology; quality of life.
Similar articles
-
The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP).J Otolaryngol Head Neck Surg. 2023 Sep 28;52(1):64. doi: 10.1186/s40463-023-00668-z. J Otolaryngol Head Neck Surg. 2023. PMID: 37759322 Free PMC article.
-
Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps.Laryngoscope. 2021 Jan;131(1):E26-E33. doi: 10.1002/lary.28648. Epub 2020 Apr 3. Laryngoscope. 2021. PMID: 32243622
-
Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps.Int Forum Allergy Rhinol. 2022 Aug;12(8):986-995. doi: 10.1002/alr.22951. Epub 2022 Jan 10. Int Forum Allergy Rhinol. 2022. PMID: 34919344
-
Biologics for chronic rhinosinusitis.Cochrane Database Syst Rev. 2021 Mar 12;3(3):CD013513. doi: 10.1002/14651858.CD013513.pub3. Cochrane Database Syst Rev. 2021. PMID: 33710614 Free PMC article.
-
Efficacy of vidian neurectomy in treating chronic rhinosinusitis with nasal polyps combined with allergic rhinitis: A systematic review and meta-analysis.Auris Nasus Larynx. 2025 Feb;52(1):28-34. doi: 10.1016/j.anl.2024.12.004. Epub 2025 Jan 8. Auris Nasus Larynx. 2025. PMID: 39787949
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical